Dr. Rolband is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
6060 Piedmont Row Dr S FL 6
Charlotte, NC 28287Phone+1 704-489-3094Fax+1 704-817-7219
Education & Training
University of California (San Diego) Medical CenterFellowship, Endocrinology, Diabetes, and Metabolism, 1989 - 1992
ECU Health Medical Center/East Carolina UniversityResidency, Internal Medicine, 1988 - 1990- ECU Health Medical Center/East Carolina UniversityInternship, Internal Medicine, 1987 - 1989
Johns Hopkins UniversityInternship, Internal Medicine, 1986 - 1987
University of Vermont College of MedicineClass of 1986
Certifications & Licensure
CA State Medical License 1990 - Present
NC State Medical License 1989 - 2025- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- Diabetes Recognition Program National Committee for Quality Assurance, 2012-2015
- Physician Practice Connections Recognition Program National Committee for Quality Assurance, 2011-2014
- Patient-Centered Medical Home Recognition Program National Committee for Quality Assurance, 2011-2014
- Join now to see all
Clinical Trials
- A Registry for Participants With Chronic Hypoparathyroidism Start of enrollment: 2013 Jul 30
Publications & Presentations
PubMed
- 41 citationsNPXY motif in the insulin-like growth factor-I receptor is required for efficient ligand-mediated receptor internalization and biological signaling.David Hsu, Paul E. Knudson, Antje Zapf, Gary C. Rolband, Jerrold M. Olefsky
Endocrinology. 1994-02-01 - 6 citationsDeletion of exon 21 of the insulin receptor eliminates tyrosine kinase activity but preserves mitogenic signaling.Gary C. Rolband, Jeffrey F. Williams, Nicholas J. G. Webster, David S. Hsu, Jerrold M. Olefsky
Biochemistry. 1993-12-14 - 4 citationsDeletion of the insulin receptor beta-subunit acidic domain results in enhanced metabolic signaling.Gary C. Rolband, Jeffrey F. Williams, Nicholas J. G. Webster, Jerrold M. Olefsky
Endocrinology. 1993-09-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
